{"id":2163,"date":"2026-07-17T13:46:33","date_gmt":"2026-07-17T10:46:33","guid":{"rendered":"https:\/\/reocell.com\/?p=2163"},"modified":"2026-07-17T13:53:28","modified_gmt":"2026-07-17T10:53:28","slug":"overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies","status":"publish","type":"post","link":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/","title":{"rendered":"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">One of the greatest challenges in modern clinical practice is that, despite the proven efficacy of many medications, a substantial proportion of patients with chronic diseases remain resistant to standard treatment. This phenomenon is closely associated with profound structural and biochemical alterations within the tissue microenvironment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Three major factors contribute to the development of treatment resistance:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Fibrosis<\/b><span style=\"font-weight: 400;\"> \u2013 excessive connective tissue deposition creates a physical barrier that limits drug diffusion and restricts cellular activity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Chronic ischemia<\/b><span style=\"font-weight: 400;\"> \u2013 prolonged impairment of microcirculation leads to tissue hypoxia and degeneration, reducing cellular responsiveness to growth factors and hormonal signals.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>A pro-inflammatory microenvironment<\/b><span style=\"font-weight: 400;\"> \u2013 persistent immune activation accompanied by increased production of pro-inflammatory cytokines creates a hostile environment that diminishes the effectiveness of anti-inflammatory and metabolic therapies.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Together, these processes create a self-perpetuating pathological cycle:<\/span><\/p>\n<p><b>Inflammation \u2192 Fibrosis \u2192 Ischemia \u2192 Treatment Resistance \u2192 Persistent Inflammation<\/b><\/p>\n<p><span style=\"font-weight: 400;\">In many patients, this cycle cannot be effectively interrupted using conventional pharmacological approaches alone.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Cell therapy, as a key component of regenerative medicine, offers a fundamentally different strategy. Rather than simply attempting to overcome tissue resistance, <\/span><b>mesenchymal stem cells (MSCs)<\/b><span style=\"font-weight: 400;\"> modify the tissue microenvironment itself, transforming it from a pro-inflammatory, ischemic, and fibrotic state into one that supports tissue repair and regeneration.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This process, known as <\/span><b>tissue microenvironment modulation<\/b><span style=\"font-weight: 400;\">, helps restore tissue responsiveness to conventional pharmacotherapy, reduce medication burden, and promote long-term remission in chronic diseases.<\/span><\/p>\n<h1><b>Mechanisms of Tissue Microenvironment Modulation<\/b><\/h1>\n<p><span style=\"font-weight: 400;\">Mesenchymal stem cells function as dynamic biological factories that reshape the tissue microenvironment through immunomodulation and regulation of cytokine signaling.<\/span><\/p>\n<h2><b>Immunomodulation: Macrophage Polarization<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">One of the principal therapeutic mechanisms of MSCs is their ability to promote the polarization of macrophages from the pro-inflammatory <\/span><b>M1 phenotype<\/b><span style=\"font-weight: 400;\"> toward the regenerative <\/span><b>M2 phenotype<\/b><span style=\"font-weight: 400;\">, thereby supporting tissue repair and wound healing.<\/span><\/p>\n<h3><b>Pro-inflammatory M1 macrophages (classically activated)<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Produce pro-inflammatory cytokines, including <\/span><b>TNF-\u03b1, IL-1\u03b2, IL-6, and IL-12<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Generate reactive oxygen species (ROS).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stimulate the activity of profibrotic fibroblasts.<\/span><\/li>\n<\/ul>\n<h3><b>Anti-inflammatory M2 macrophages (alternatively activated)<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Produce anti-inflammatory cytokines, including <\/span><b>IL-10, TGF-\u03b2, and IL-4<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Secrete angiogenic growth factors such as <\/span><b>VEGF<\/b><span style=\"font-weight: 400;\"> and <\/span><b>FGF<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Release matrix metalloproteinases (<\/span><b>MMP-9<\/b><span style=\"font-weight: 400;\">).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Promote tissue regeneration through regenerative cytokines and growth factors.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">MSC-induced macrophage polarization is mediated through the secretion of several bioactive molecules, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Prostaglandin E2 (PGE2)<\/b><span style=\"font-weight: 400;\">, a potent regulator of macrophage signaling pathways.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Transforming growth factor-\u03b2 (TGF-\u03b2)<\/b><span style=\"font-weight: 400;\">, a key cytokine that promotes M2 differentiation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Indoleamine 2,3-dioxygenase (IDO)<\/b><span style=\"font-weight: 400;\">, an enzyme that contributes to immune tolerance.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">As a result of this phenotypic shift, MSCs help:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Reduce fibrosis.<\/b><span style=\"font-weight: 400;\"> Matrix metalloproteinases released by M2 macrophages remodel type I collagen, facilitating the formation of new blood vessels within fibrotic tissue.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Suppress excessive inflammatory signaling.<\/b><span style=\"font-weight: 400;\"> MSCs inhibit the secretion of pro-inflammatory cytokines while increasing IL-10 production, helping interrupt the cycle of uncontrolled immune activation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Restore tissue homeostasis.<\/b><span style=\"font-weight: 400;\"> By reactivating endogenous repair mechanisms suppressed by chronic inflammation, MSCs promote a regenerative tissue environment.<\/span><\/li>\n<\/ul>\n<h2><b>Suppression of Systemic Inflammation Through Cytokine Modulation<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">MSCs effectively suppress persistent inflammatory signaling and create a therapeutic window for restoring tissue homeostasis by reducing the levels of key systemic inflammatory mediators, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Tumor necrosis factor-\u03b1 (TNF-\u03b1)<\/b><span style=\"font-weight: 400;\"> \u2013 one of the principal cytokines responsible for maintaining chronic inflammation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Interleukin-6 (IL-6)<\/b><span style=\"font-weight: 400;\"> \u2013 a major mediator of the acute-phase response and systemic inflammation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Interleukin-1\u03b2 (IL-1\u03b2)<\/b><span style=\"font-weight: 400;\"> \u2013 a potent pro-inflammatory cytokine that initiates and amplifies inflammatory cascades.<\/span><\/li>\n<\/ul>\n<h2><b>Revascularization and Restoration of Tissue Perfusion<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Chronic ischemia is more than a simple deficiency of oxygen supply. It represents a complex pathological condition characterized by impaired angiogenesis and reduced responsiveness to regulatory signaling.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">MSCs help restore tissue function by secreting key regenerative growth factors, including:<\/span><\/p>\n<h3><b>Vascular Endothelial Growth Factor (VEGF)<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">VEGF is the primary driver of therapeutic angiogenesis. It stimulates the proliferation and migration of endothelial cells, promoting the formation of new capillaries within ischemic tissues.<\/span><\/p>\n<h3><b>Hepatocyte Growth Factor (HGF)<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">HGF is a multifunctional growth factor that acts on multiple cell types. It:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">activates signaling pathways that enhance endothelial cell survival under hypoxic conditions;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">exerts anti-inflammatory effects by suppressing TNF-\u03b1 activity;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">promotes fibroblast migration and extracellular matrix remodeling.<\/span><\/li>\n<\/ul>\n<h2><b>Restoring Cellular Responsiveness and Overcoming Metabolic Dysfunction<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">In many chronic diseases, metabolic dysfunction develops as a consequence of cofactor depletion, accumulation of toxic metabolic intermediates, and impaired enzyme activity.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">MSCs help overcome these metabolic barriers by activating alternative metabolic pathways and improving mitochondrial function. As a result, they enhance cellular responsiveness to regulatory signals and may contribute to improved insulin sensitivity.<\/span><\/p>\n<h1><b>Clinical Synergy: Combining MSC Therapy with Conventional Treatment<\/b><\/h1>\n<p><span style=\"font-weight: 400;\">Cell-based therapies are designed to complement\u2014not replace\u2014established medical treatments.<\/span><\/p>\n<h2><b>Endocrinology: The Adjuvant Role of MSCs in Insulin Therapy<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The use of mesenchymal stem cells as an adjunctive therapy represents one of the most promising developments in modern endocrinology. The objective is not simply to compensate for insulin deficiency but to address the underlying mechanisms of diabetes, thereby improving treatment efficacy, reducing medication requirements, and helping prevent long-term complications.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">MSCs exert multiple therapeutic effects by:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">reducing chronic systemic inflammation, a major contributor to treatment resistance;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">modulating the balance between T helper 1 (Th1) and T helper 2 (Th2) immune responses;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">improving microcirculation within insulin-responsive tissues, thereby facilitating insulin delivery and utilization;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">promoting the expansion of regulatory T cells (Tregs), which help protect pancreatic islets from immune-mediated damage;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">creating a supportive microenvironment for pancreatic \u03b2-cells responsible for insulin production.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">When combined with conventional insulin therapy, MSC treatment has been associated with the potential to:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">reduce inflammation and slow autoimmune destruction;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">improve tissue vascularization;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">protect cells from oxidative stress;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">enhance endogenous insulin secretion;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">improve glucose tolerance and stabilize blood glucose levels;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">reduce glucotoxicity in target tissues;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">lower glycated hemoglobin (HbA1c);<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">improve the effectiveness of insulin therapy;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">decrease daily insulin requirements;<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">reduce fluctuations between hypoglycemia and hyperglycemia.<\/span><\/li>\n<\/ul>\n<p><b>Important:<\/b><span style=\"font-weight: 400;\"> MSC therapy is not intended to replace insulin therapy. Instead, it serves as a complementary treatment strategy aimed at optimizing metabolic control, supporting long-term disease remission, and improving overall clinical stability.<\/span><\/p>\n<h2><b>Rheumatology and Orthopedics: Combining MSC Therapy with Conventional Treatment to Restore Cartilage Homeostasis<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Healthy cartilage exists in a dynamic balance between <\/span><b>anabolism<\/b><span style=\"font-weight: 400;\">\u2014the synthesis of type II collagen and proteoglycans\u2014and <\/span><b>catabolism<\/b><span style=\"font-weight: 400;\">, the breakdown of the extracellular matrix mediated by matrix metalloproteinases.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In osteoarthritis and rheumatoid arthritis, this balance shifts toward progressive tissue degradation, resulting in collagen breakdown, cartilage deterioration, and chronic hypoxia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The greatest therapeutic benefit can be achieved through a <\/span><b>combined treatment approach<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">MSCs provide both regenerative potential and a powerful paracrine effect. They can differentiate into chondrocytes and release exosomes that help suppress inflammation and support cartilage repair.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Conventional therapies create a favorable microenvironment for regeneration:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Chondroprotective agents<\/b><span style=\"font-weight: 400;\"> provide the building blocks required for extracellular matrix synthesis and help stabilize cartilage metabolism over time.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Hyaluronic acid injections<\/b><span style=\"font-weight: 400;\"> improve joint lubrication and provide mechanical support for newly regenerated tissue.<\/span><\/li>\n<\/ul>\n<style>\n.post-table{width:100%;border-collapse:collapse;margin:1.5em 0;font-size:.95em}\n.post-table th,.post-table td{border:1px solid #d0d0d0;padding:10px 12px;vertical-align:top;text-align:left}\n.post-table th{background:#f5f5f5;font-weight:600}\n.post-table tr:nth-child(even) td{background:#fafafa}\n@media (max-width:600px){.post-table{display:block;overflow-x:auto}}\n<\/style>\n<table class=\"post-table\">\n<thead>\n<tr>\n<th>Treatment<\/th>\n<th>Primary Effect on Cartilage<\/th>\n<th>Role in Combination Therapy<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Conventional therapy<\/td>\n<td>Controls inflammation and supports cartilage metabolism<\/td>\n<td>Provides protection and prepares the tissue environment<\/td>\n<\/tr>\n<tr>\n<td>MSC therapy<\/td>\n<td>Promotes regeneration and repair of cartilage defects<\/td>\n<td>Drives active tissue regeneration<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">When conventional therapy is used alone, it may successfully control inflammation but cannot restore cartilage structure or repair the synovial membrane after years of chronic degeneration.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Conversely, MSC therapy alone may also be insufficient. Without adequate control of the inflammatory environment provided by conventional treatment, transplanted MSCs may differentiate into fibrotic tissue rather than functional chondrocytes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In other words, <\/span><b>conventional therapy prepares the ground, while MSC therapy plants the seeds for regeneration.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">By combining MSC therapy with disease-modifying antirheumatic drugs (DMARDs), chondroprotective agents, and other standard treatments, clinicians can not only relieve symptoms but also slow cartilage degeneration, restore cartilage homeostasis, delay joint replacement surgery, and improve quality of life through better joint biomechanics.<\/span><\/p>\n<h2><b>A New Perspective on Therapeutic Potency<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">According to the latest <\/span><b>ISCT 2025 (International Society for Cell &amp; Gene Therapy)<\/b><span style=\"font-weight: 400;\"> recommendations, the assessment of MSC therapeutic potential has evolved beyond the analysis of surface markers alone.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Increasing emphasis is now placed on the <\/span><b>Potency Matrix<\/b><span style=\"font-weight: 400;\">, an approach that quantitatively evaluates the functional capacity of MSCs to modulate specific pathological processes\u2014including immunosuppression, angiogenesis, and anti-fibrotic activity\u2014before clinical administration.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Recent clinical studies suggest that the multimodal activity of MSCs within the tissue microenvironment may help overcome the <\/span><b>epigenetic memory<\/b><span style=\"font-weight: 400;\"> associated with chronic inflammation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These findings also indicate that, without prior restoration of the tissue niche, conventional pharmacotherapy may remain less effective because of persistent structural and biochemical barriers.<\/span><\/p>\n<h1><b>The &#8220;Hit-and-Run&#8221; Mechanism: A Therapeutic Paradox<\/b><\/h1>\n<p><span style=\"font-weight: 400;\">One of the most fascinating aspects of MSC therapy is the apparent paradox of <\/span><b>long-lasting clinical benefits despite the short-lived presence of transplanted cells<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Following intravenous administration, circulating MSC levels typically peak within the first <\/span><b>2\u20136 hours<\/b><span style=\"font-weight: 400;\">. More than <\/span><b>98%<\/b><span style=\"font-weight: 400;\"> of infused cells are cleared from the body within <\/span><b>24\u201348 hours<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Nevertheless, therapeutic effects\u2014including reduced inflammation and enhanced tissue regeneration\u2014generally become evident over the following <\/span><b>2\u20134 weeks<\/b><span style=\"font-weight: 400;\"> and may persist for <\/span><b>6\u201312 months<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">How can such durable clinical effects occur when the transplanted cells survive for only a few days?<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The answer lies primarily in the <\/span><b>MSC secretome<\/b><span style=\"font-weight: 400;\">\u2014a complex mixture of soluble signaling molecules, cytokines, growth factors, and extracellular vesicles released by MSCs into the surrounding tissue microenvironment.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Among these secreted components, <\/span><b>exosomes<\/b><span style=\"font-weight: 400;\"> represent one of the most important mediators of paracrine signaling. Their nanoscale size allows them to penetrate biological barriers and reach deep tissue compartments that are often inaccessible to many conventional therapeutic agents.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Unlike isolated growth factors, exosomes carry coordinated signaling complexes capable of initiating self-sustaining regenerative cascades. They activate resident tissue cells\u2014including macrophages, fibroblasts, and osteoblasts\u2014stimulating prolonged production of endogenous growth factors and cytokines.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This biological amplification mechanism helps explain how a single administration of MSCs may produce therapeutic effects that last for months without repeated cell transplantation.<\/span><\/p>\n<h1><b>Reducing Pharmacological Burden Through Cell-Based Therapies<\/b><\/h1>\n<p><span style=\"font-weight: 400;\">Despite the continuous development of new pharmaceuticals, modern medicine faces an increasing challenge: <\/span><b>polypharmacy<\/b><span style=\"font-weight: 400;\">. Patients with multiple chronic conditions often require 10\u201315 medications daily, increasing the risk of adverse effects, drug interactions, and reduced treatment adherence.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Mesenchymal stem cells offer a fundamentally different therapeutic strategy.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Rather than simply alleviating symptoms, MSC therapy targets the underlying mechanisms of disease. By modulating the tissue microenvironment, MSCs help restore tissue responsiveness to treatment, creating conditions that support endogenous repair and regeneration.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This approach has the potential to shift clinical practice from symptom management toward <\/span><b>pathogenesis-oriented regenerative therapy<\/b><span style=\"font-weight: 400;\">, where conventional pharmacological treatments and regenerative technologies work synergistically rather than independently.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As tissue responsiveness improves, clinicians may be able to optimize treatment regimens, reduce medication burden, and achieve more durable disease control.<\/span><\/p>\n<h1><b>Conclusion<\/b><\/h1>\n<p><span style=\"font-weight: 400;\">Mesenchymal stem cells should not be viewed as a replacement for conventional pharmacotherapy. Instead, they represent a promising adjunctive therapeutic strategy capable of enhancing the effectiveness of established treatments.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">By modulating the tissue microenvironment, reducing chronic inflammation, promoting angiogenesis, and supporting endogenous repair mechanisms, MSCs help restore tissue responsiveness to therapy while addressing key drivers of treatment resistance.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Growing experimental and clinical evidence suggests that combining MSC therapy with standard medical treatment may improve long-term outcomes across a range of chronic diseases. As research continues to advance, this integrative approach has the potential to become an important component of future regenerative medicine strategies.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>One of the greatest challenges in modern clinical practice is that, despite the proven efficacy of many medications, a substantial proportion of patients with chronic diseases remain resistant to standard treatment. This phenomenon is closely associated with profound structural and biochemical alterations within the tissue [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"post-type":[],"post-whom":[],"service":[],"material":[],"whom":[],"class_list":["post-2163","post","type-post","status-publish","format-standard","hentry","category-bez-kategoriyi"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell\" \/>\n<meta property=\"og:description\" content=\"One of the greatest challenges in modern clinical practice is that, despite the proven efficacy of many medications, a substantial proportion of patients with chronic diseases remain resistant to standard treatment. This phenomenon is closely associated with profound structural and biochemical alterations within the tissue [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Reocell\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-17T10:46:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-17T10:53:28+00:00\" \/>\n<meta name=\"author\" content=\"SEO MedUP\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SEO MedUP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/\"},\"author\":{\"name\":\"SEO MedUP\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/44bee65b347c032c71d4a04c1bf7423d\"},\"headline\":\"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies\",\"datePublished\":\"2026-07-17T10:46:33+00:00\",\"dateModified\":\"2026-07-17T10:53:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/\"},\"wordCount\":1824,\"articleSection\":[\"\u0411\u0435\u0437 \u043a\u0430\u0442\u0435\u0433\u043e\u0440\u0456\u0457\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/\",\"url\":\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/\",\"name\":\"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#website\"},\"datePublished\":\"2026-07-17T10:46:33+00:00\",\"dateModified\":\"2026-07-17T10:53:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/44bee65b347c032c71d4a04c1bf7423d\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/reocell.com\\\/en\\\/blog\\\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/reocell.com\\\/en\\\/\",\"name\":\"Reocell\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/reocell.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/44bee65b347c032c71d4a04c1bf7423d\",\"name\":\"SEO MedUP\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/","og_locale":"en_US","og_type":"article","og_title":"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell","og_description":"One of the greatest challenges in modern clinical practice is that, despite the proven efficacy of many medications, a substantial proportion of patients with chronic diseases remain resistant to standard treatment. This phenomenon is closely associated with profound structural and biochemical alterations within the tissue [&hellip;]","og_url":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/","og_site_name":"Reocell","article_published_time":"2026-07-17T10:46:33+00:00","article_modified_time":"2026-07-17T10:53:28+00:00","author":"SEO MedUP","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SEO MedUP","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/#article","isPartOf":{"@id":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/"},"author":{"name":"SEO MedUP","@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/44bee65b347c032c71d4a04c1bf7423d"},"headline":"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies","datePublished":"2026-07-17T10:46:33+00:00","dateModified":"2026-07-17T10:53:28+00:00","mainEntityOfPage":{"@id":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/"},"wordCount":1824,"articleSection":["\u0411\u0435\u0437 \u043a\u0430\u0442\u0435\u0433\u043e\u0440\u0456\u0457"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/","url":"https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/","name":"Overcoming Treatment Resistance: Combining Mesenchymal Stem Cells with Conventional Therapies - Reocell","isPartOf":{"@id":"https:\/\/reocell.com\/en\/#website"},"datePublished":"2026-07-17T10:46:33+00:00","dateModified":"2026-07-17T10:53:28+00:00","author":{"@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/44bee65b347c032c71d4a04c1bf7423d"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reocell.com\/en\/blog\/overcoming-treatment-resistance-combining-mesenchymal-stem-cells-with-conventional-therapies\/"]}]},{"@type":"WebSite","@id":"https:\/\/reocell.com\/en\/#website","url":"https:\/\/reocell.com\/en\/","name":"Reocell","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reocell.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/44bee65b347c032c71d4a04c1bf7423d","name":"SEO MedUP"}]}},"_links":{"self":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts\/2163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/comments?post=2163"}],"version-history":[{"count":0,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts\/2163\/revisions"}],"wp:attachment":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/media?parent=2163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/categories?post=2163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/tags?post=2163"},{"taxonomy":"post-type","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/post-type?post=2163"},{"taxonomy":"post-whom","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/post-whom?post=2163"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/service?post=2163"},{"taxonomy":"material","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/material?post=2163"},{"taxonomy":"whom","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/whom?post=2163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}